A study coauthored by Stanford Healthcare and Included Health that was looking into the efficacy of digital tools in managing chronic ailments has found that telehealth services have had a net positive impact on patients with hypertension.
While digital health may be relatively new, the coronavirus pandemic was a game-changer for the field. With millions of people in locked-down areas and hospitals filling with coronavirus patients, a lot of people could not receive in-person medical care. However, thanks to digital tools such as phone calls and video calls, people battling chronic ailments were still able to stay up-to-date with their treatments. Data shows that digital health technology can help lower A1C levels and prevent prediabetics from progressing to type 2 diabetes, which only makes it clear that these tools work.
Early this year, Hello Health revealed an independent study showing that its digital cardiac app, which is powered by machine learning tech, helped patients avoid surgeries and invasive procedures. And just a couple of days ago, a study published in Mayo Clinic Proceedings showed that a digital-first treatment approach can be extremely effective when it comes to managing hypertension.
The peer-reviewed study revealed that 77% of patients had a mean reduction of -9.7 mm Hg in systolic blood pressure and -6.8 mm Hg in diastolic blood pressure. Study co-author and affiliated clinical assistant professor at Stanford Medicine Dr. Shriram Nallamshetty stated that digital health had proven to be an effective way of providing better hypertension care.
This is especially crucial as recent reports show that the quality of hypertension care in the United States has been on a steady decline over the past decade. Moving forward, Nallamshetty argued that it was important to consider the ways digital health tools could improve how physicians combat chronic ailments.
Similarly, Included Health’s chief medical officer Ian Tong stated that data from the study had shown that virtual care could be an alternative solution to managing chronic conditions such as hypertension when in-person visits simply weren’t possible. He added that it was important to explore new ways to improve access to quality medical care for people suffering from chronic conditions, when they needed it. Included Health is focused on doing just that.
Birthed from the merger of Doctor on Demand and Grand Rounds, Included Health provides patients with a virtual primary care physician coupled with the option of virtual urgent care visits. Additionally, the San Francisco-based company can organize in-person visits with a medical professional if virtual care isn’t possible.
These studies validating the usefulness of digital tools in helping patients manage the chronic diseases afflicting them is a significant encouragement to companies such as Nemaura Medical Inc. (NASDAQ: NMRD), which are focused on developing cutting-edge technologies targeting patients with chronic disease indications.
NOTE TO INVESTORS: The latest news and updates relating to Nemaura Medical Inc. (NASDAQ: NMRD) are available in the company’s newsroom at https://ibn.fm/NMRD
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.